Zacks Investment Research Analysts Give Alere Inc (NYSE: ALR) an “Underperform” Rating

diagnostics and health management solutions. The Company’s products and services are focused on infectious disease, cardiology, oncology, drugs of abuse and women’s health. Its brands range from over-the-counter tests to lab-based diagnostics to
Moreover Technologies – Search results for… drugs – 30 of 764 returned

Leave a Reply